Dietrich C P, Armelin H A, Nogueira Y L, Nader H B, Michelacci Y M
Biochim Biophys Acta. 1982 Aug 27;717(3):387-97. doi: 10.1016/0304-4165(82)90279-3.
The synthesis of sulfated glycosaminoglycans was analysed in mouse fibroblasts during the transition from exponential growth to quiescent monolayers. 'Normal' Swiss 3T3 fibroblasts were compared with SV40 transformed 3T3, C6, ST1 and HeLa cells. p-Nitrophenyl-beta-D-xyloside, an artificial acceptor for glycosaminoglycans synthesis, was used as a probe. Exponentially growing 'normal' 3T3 cells synthesized both dermatan sulfate and chondroitin 4-sulfate, retaining the latter and releasing the former to the medium. Upon reaching quiescence these cells switched to retention of dermatan sulfate and release of chondroitin 4-sulfate. SV3T3 cells synthesized several fold less sulfated glycosaminoglycans than 'normal' 3T3. Even though SV3T3 cells are able to synthesize dermatan sulfate, they only retained chondroitin 4-sulfate, never switching to retention of dermatan sulfate. These results indicated that the transition from rapidly proliferating to resting G0 state in normal cells is accompanied by a switch from chondroitin-sulfate rich to dermatan-sulfate-rich cells. This switching was not observed with transformed cells, which are unable to enter the G0 state. Phenylxyloside caused a several fold increase in glycosaminoglycans released to the medium in both cell types, but it did not interfere with either growth rate or cell morphology. Particularly the phenylxyloside treatment led to an increase of more than 10-fold in production of dermatan and chondroitin sulfate by SV3T3, C6, ST1 and HeLa cells. This demonstrated that transformed cells have a high capacity for glycosaminoglycan synthesis. Analysis of enzymatic degradation products of glycosaminoglycans, synthesized in the presence of phenylxyloside, by normal and transformed cells, led to the finding of 4- and 6-sulfated iduronic and glucuronic acid-containing disaccharides. This result indicated that the xyloside causes the synthesis of a peculiar chondroitin sulfate/dermatan sulfate, in both normal and transformed cells.
在小鼠成纤维细胞从指数生长转变为静止单层细胞的过程中,对硫酸化糖胺聚糖的合成进行了分析。将“正常”的瑞士3T3成纤维细胞与SV40转化的3T3、C6、ST1和HeLa细胞进行比较。对硝基苯基-β-D-木糖苷,一种糖胺聚糖合成的人工受体,被用作探针。指数生长的“正常”3T3细胞合成硫酸皮肤素和硫酸软骨素4-硫酸酯,保留后者并将前者释放到培养基中。达到静止状态后,这些细胞转而保留硫酸皮肤素并释放硫酸软骨素4-硫酸酯。SV3T3细胞合成的硫酸化糖胺聚糖比“正常”3T3细胞少几倍。尽管SV3T3细胞能够合成硫酸皮肤素,但它们只保留硫酸软骨素4-硫酸酯,从不转而保留硫酸皮肤素。这些结果表明,正常细胞从快速增殖状态转变为静止的G0状态伴随着从富含硫酸软骨素的细胞向富含硫酸皮肤素的细胞的转变。在转化细胞中未观察到这种转变,因为它们无法进入G0状态。苯基木糖苷使两种细胞类型释放到培养基中的糖胺聚糖增加了几倍,但它不影响生长速率或细胞形态。特别是苯基木糖苷处理使SV3T3、C6、ST1和HeLa细胞产生的硫酸皮肤素和硫酸软骨素增加了10倍以上。这表明转化细胞具有很高的糖胺聚糖合成能力。对在苯基木糖苷存在下正常细胞和转化细胞合成的糖胺聚糖的酶促降解产物进行分析,发现了含有4-和6-硫酸化艾杜糖醛酸和葡萄糖醛酸的二糖。这一结果表明,木糖苷在正常细胞和转化细胞中都能导致一种特殊的硫酸软骨素/硫酸皮肤素的合成。